,i  #aagth ,,congress  #ast ,session    
,h4 ,r4 #ecca  ,,in ,,the ,,house ,,of  
,,representatives  ,september #bb1      
#bjba,mr4 ,danny ,k4 ,davis of ,illinois
 7for himself1 ,mr4 ,rush1 ,mr4         
,wenstrup1 and ,mr4 ,hollingsworth7     
introduced the following bill2 which was
 referred to the ,committee on ,energy  
and ,commerce1 and in addition to the   
,committee on ,ways and ,means1 for a   
period to be subsequently determined by 
the ,speaker1 in each case for          
consideration of such provisions as fall
 within the jurisdiction of the         
committee concerned  ,a ,,bill  ,to     
amend title ,,xviii of the ,social      
,security ,act to improve access to     
innovative new medical devices furnished
 to individuals with end stage renal    
disease under part ,b of the ,medicare  
program by establishing a new device    
add-on payment adjustment under such    
part4  #a4 ,short title ,this ,act may  
be cited as the ,patient ,access to     
,,esrd ,new ,innovative ,devices ,act4  

#b4 ,findings ,congress finds the       
following3 7#a7 ,there are approximately
 #djj1jjj ,medicare beneficiaries with  
end-stage renal disease1 making up #a   
percent of the ,medicare population but 
accounting for approximately #g percent 
of all ,medicare spending4  7#b7        
,expected remaining lifetime for        
dialysis patients under #hj years old is
 one-third as long as their counterparts
 without ,,esrd1 and for dialysis       
patients over #hj years old1 it is      
one-half as long as that of their       
counterparts without ,,esrd4  7#c7 ,on  
average1 hemodialysis patients are      
hospitalized nearly twice per year and  
about #cj percent have an unplanned     
rehospitalization within the #cj days   
following discharge1 contributing to    
high costs for treating ,,esrd ,medicare
 beneficiaries4  7#d7 ,there is a lack  
of innovative new devices for ,,esrd    
,medicare beneficiaries1 in part because
 of the lack of reimbursement incentives
 for novel devices4  #c4 ,temporary     

add-on payment for new medical devices  
to diagnose1 treat1 or manage end stage 
renal disease ,the ,secretary of ,health
 and ,human ,services shall provide--   
7#a7 a three-year temporary add-on      
payment adjustment 7as described in     
section #dac4bcf7;d7 of title #db1 ,code
 of ,federal ,regulations7 for a new    
medical device approved by the ,food and
 ,drug ,administration under section    
#eac7;f77#b7 of the ,federal ,food1     
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #cfj;c7 on or after ,january #a1 #bjbj1
 and furnished to an individual entitled
 to benefits under part ,b of title     
,,xviii of the ,social ,security ,act   
for the diagnosis1 treatment1 or        
management of end stage renal disease2  
and  7#b7 for the adjustment under      
paragraph 7#a7 to be implemented in a   
nonbudget neutral manner under          
subparagraph 7,d77iv7 of section        
#ahha7;b77#ad7 of the ,social ,security 
,act 7#db ,u4,s4,c4                     
#acierr7b77#ad77;,d77iv774